Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

NCT00366509 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00366509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00366509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
September 18, 2006
Completion date
October 27, 2016
Enrollment
157 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, lymphangioleiomyomatosis, oropharyngeal disease, pulmonary disease, pulmonary fibrosis, sarcoidosis